Experienced in Typhoid Fever

Lars Rombo

Uppsala, C, SE 
Experienced in Typhoid Fever
Uppsala, C, SE 
OverviewLocationsClinical Research

Overview

Lars Rombo practices in Uppsala, Sweden. Mr. Rombo is rated as an Experienced expert by MediFind in the treatment of Typhoid Fever. His top areas of expertise are Hepatitis A, Japanese Encephalitis, Encephalitis, and Shingles.

His clinical research consists of co-authoring 54 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Typhoid Fever.

Gender
Male

Locations

Uppsala, C, Sweden
Other Locations
Eskilstuna, D, Sweden
Oerebro, T, Sweden
Stockholm, AB, Sweden
Solna, AB 17176, Sweden
Karolinska Institutet, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Immune Response to Pneumococcal Conjugate Vaccine in Adults Receiving Hepatitis a Vaccine At the Same Time
Immune Response to Pneumococcal Conjugate Vaccine in Adults Receiving Hepatitis a Vaccine At the Same Time
Enrollment Status: Completed
Publish Date: December 05, 2024
Intervention Type: Biological
Study Phase: Phase 4
A Phase 3, Randomized, Double-blind, Multi-country Study to Evaluate Consistency, Safety, and Reactogenicity of 3 Lots of RSVPreF3 OA Investigational Vaccine Administrated as a Single Dose in Adults Aged 60 Years and Above
A Phase 3, Randomized, Double-blind, Multi-country Study to Evaluate Consistency, Safety, and Reactogenicity of 3 Lots of RSVPreF3 OA Investigational Vaccine Administrated as a Single Dose in Adults Aged 60 Years and Above
Enrollment Status: Completed
Publish Date: February 15, 2023
Intervention Type: Biological
Study Phase: Phase 3
Humoral Response to TBE Vaccine in Elderly (50+ Year Olds) After Changed Dosage Intervals/Number of Doses?
Humoral Response to TBE Vaccine in Elderly (50+ Year Olds) After Changed Dosage Intervals/Number of Doses?
Enrollment Status: Completed
Publish Date: February 10, 2021
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
View 2 Less Clinical Trials

54 Total Publications

Risk factors for further recurrences of Clostridioides difficile infection at the first and second recurrence: a retrospective cohort.
Risk factors for further recurrences of Clostridioides difficile infection at the first and second recurrence: a retrospective cohort.
Journal: BMC infectious diseases
Published: June 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rombo's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile